Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance

Tuberculosis

Volumn 85, Issue 5-6, 2005, Pages 367-376

  Mustafa, Abu Salim ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Diagnosis; Recombinant antigens; Synthetic peptides; Tuberculosis; Vaccines

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BCG VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; EPITOPE; MYCOBACTERIUM TUBERCULOSIS ANTIGEN; PROTEIN; PROTEIN CFP 10; PROTEIN PE; PROTEIN PPE; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGENICITY; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; CELLULAR IMMUNITY; CONFERENCE PAPER; GENE DELETION; GENE LOCATION; HLA SYSTEM; HUMAN; IMMUNOREACTIVITY; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS;

ANTIGENS, BACTERIAL; EPITOPES; GENE DELETION; GENETIC ENGINEERING; GENOMICS; HLA-DR ANTIGENS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 27744570919     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2005.08.006     Document Type: Conference Paper

References (56)

1. M.F. Iademarco, and K.G. Castro Epidemiology of tuberculosis Semin Respir Infect 18 2003 225 240
2. T.R. Frieden, T.R. Sterling, S.S. Munsiff, C.J. Watt, and C. Dye Tuberculosis Lancet 362 2003 887 899
3. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
4. D. Schlossberg Tuberculosis and nontuberculous mycobacterial infections 4th ed 1999 W.B. Saunders Company UK [p. 3]
5. A.S. Mustafa Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis Curr Pharm Biotechnol 2 2001 157 173
6. A.S. Mustafa Development of new vaccines and diagnostic reagents against tuberculosis Mol Immunol 39 2002 113 119
7. Mustafa AS. Progress towards the development of new anti-tuberculosis vaccines. In: Smithe LT, editor. Focus on Tuberculosis Research. Nova Publishers; p. 47-76.
8. G.G. Mahairas, P.J. Sabo, M.J. Hickey, D.C. Singh, and C.K. Stover Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis J Bacteriol 178 1996 1274 1282
9. T.F. Brewer, and G.A. Colditz Relationship between Bacille Calmette-Guerin strains and the efficacy of BCG vaccine in the prevention of tuberculosis Clin Infect Dis 20 1995 126 135
10. G.A. Colditz, C.S. Berkey, F. Mosteller, T.F. Brewer, M.E. Wilson, and E. Burdick The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics 96 1995 29 35
11. F.X. Berthet, P.B. Rasmussen, I. Rosenkrands, P. Andersen, and B. Gicquel A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10) Microbiology 144 1998 3195 3203
12. R.L. Skjot, T. Oettinger, I. Rosenkrands, P. Ravn, I. Brock, and S. Jacobsen Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens Infect Immun 68 2000 214 220
13. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, and D. Harris Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 1998 537 544
14. S. Ahmad, H.A. Amoudy, J.E. Thole, D.B. Young, and A.S. Mustafa Identification of a novel protein antigen encoded by a Mycobacterium tuberculosis-specific RD1 region gene Scand J Immunol 49 1999 515 522
15. A.S. Mustafa, and R. Al-Attiyah Tuberculosis: looking beyond BCG vaccines J Postgrad Med 49 2003 134 140
16. S. Ahmad, M.M. Ali, and A.S. Mustafa Construction of a modified vector for efficient purification of recombinant Mycobacterium tuberculosis proteins expressed in Escherichia coli Protein Expr Purif 29 2003 167 175
17. A.S. Mustafa Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and Mycobacterium w Int J Lepr Other Mycobact Dis 56 1988 265 273
18. A.S. Mustafa, K.E. Lundin, R.H. Meloen, and F. Oftung Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein Clin Exp Immunol 120 2000 85 92
19. A.S. Mustafa, K.E. Lundin, R.H. Meloen, T.M. Shinnick, and F. Oftung Identification of promiscuous epitopes from the mycobacterial 65-kilodalton heat shock protein recognized by human CD4(+) T cells of the Mycobacterium leprae memory repertoire Infect Immun 67 1999 5683 5689
20. T. Mutis, Y.E. Cornelisse, G. Datema, P.J. van den Elsen, T.H. Ottenhoff, and R.R. de Vries Definition of a human suppressor T-cell epitope Proc Natl Acad Sci USA 91 1994 9456 9460
21. S.M. Arend, A. Geluk, K.E. van Meijgaarden, J.T. van Dissel, M. Theisen, and P. Andersen Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides Infect Immun 68 2000 3314 3321
22. A.S. Mustafa, P.J. Cockle, F. Shaban, R.G. Hewinson, and H.M. Vordermeier Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle Clin Exp Immunol 130 2002 37 42
23. H.M. Vordermeier, A. Whelan, P.J. Cockle, L. Farrant, N. Palmer, and R.G. Hewinson Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle Clin Diagn Lab Immunol 8 2001 571 578
24. F. Oftung, K.E.A. Lundin, A. Geluk, T.M. Shinnick, R. Meloen, and A.S. Mustafa Primary structure and MHC restriction of peptide defined T cell epitopes from recombinantly expressed mycobacterial protein antigens Med Principles Pract 6 1997 66 73
25. M.E. Munk, S.M. Arend, I. Brock, T.H.M. Ottenhoff, and P. Andersen Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis J Infect Dis 183 2001 175 176
26. A.A. Pathan, K.A. Wilkinson, P. Klenerman, H. McShane, R.N. Davidson, and G. Pasvol Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment J Immunol 167 2001 5217 5225
27. B.A. Wu-Hsieh, C.K. Chen, J.H. Chang, S.Y. Lai, C.H. Wu, and W.C. Cheng Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis Clin Infect Dis 33 2001 1336 1340
28. R. Al-Attiyah, A.S. Mustafa, A.T. Abal, N.M. Madi, and P. Andersen Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy FEMS Immunol Med Microbiol 38 2003 249 256
29. A.L. Chapman, M. Munkanta, K.A. Wilkinson, A.A. Pathan, K. Ewer, and H. Ayles Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells AIDS 16 2002 2285 2293
30. F.L. Cardoso, P.R. Antas, A.S. Milagres, A. Geluk, K.L. Franken, and E.B. Oliveira T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients Infect Immun 70 2002 6707 6714
31. R. Al-Attiyah, F.A. Shaban, H.G. Wiker, F. Oftung, and A.S. Mustafa Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70 Infect Immun 71 2003 1953 1960
32. A. Lalvani, P. Nagvenkar, Z. Udwadia, A.A. Pathan, K.A. Wilkinson, and J.S. Shastri Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians J Infect Dis 183 2001 469 477
33. A.A. Pathan, K.A. Wilkinson, R.J. Wilkinson, M. Latif, H. McShane, and G. Pasvol High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease Eur J Immunol 30 2000 2713 2721
34. L.M. Okkels, I. Brock, F. Follmann, E.M. Agger, S.M. Arend, and T.H. Ottenhoff PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family Infect Immun 71 2003 6116 6123
35. P.J. Cockle, S.V. Gordon, A. Lalvani, B.M. Buddle, R.G. Hewinson, and H.M. Vordermeier Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics Infect Immun 70 2002 6996 7003
36. M.A. Behr, M.A. Wilson, W.P. Gill, H. Salamon, G.K. Schoolnik, and S. Rane Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 284 1999 1520 1523
37. S.V. Gordon, R. Brosch, A. Billault, T. Garnier, K. Eiglmeier, and S.T. Cole Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays Mol Microbiol 32 1999 643 655
38. R. Brosch, S.V. Gordon, A. Pym, K. Eiglmeier, T. Garnier, and S.T. Cole Comparative genomics of the mycobacteria Int J Med Microbiol 290 2000 143 152
39. P. Ravn, A. Demissie, T. Eguale, H. Wondwosson, D. Lein, and H.A. Amoudy Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis J Infect Dis 179 1999 637 645
40. S.M. Arend, K.E. van Meijgaarden, K. de Boer, E.C. de Palou, D. van Soolingen, and T.H. Ottenhoff Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii J Infect Dis 186 2002 1797 1807
41. H.M. Vordermeier, A. Whelan, P.J. Cockle, L. Farrant, N. Palmer, and R.G. Hewinson Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle Clin Diagn Lab Immunol 8 2001 571 578
42. A.W. Olsen, P.R. Hansen, A. Holm, and P. Andersen Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen Eur J Immunol 30 2000 1724 1732
43. A.S. Mustafa, F.A. Shaban, A.T. Abal, R. Al-Attiyah, H.G. Wiker, and K.E. Lundin Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines Infect Immun 68 2000 3933 3940
44. R. Al-Attiyah, F.A. Shaban, H.G. Wiker, F. Oftung, and A.S. Mustafa Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70 Infect Immun 71 2003 1953 1960
45. R. Al-Attiyah, and A.S. Mustafa Computer-assisted prediction of HLA-DR binding and experimental analysis for human promiscuous Th1 cell epitopes in a novel 24-kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis Scand J Immunol 59 2004 16 24
46. A.S. Mustafa HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design Hum Immunol 61 2000 166 171
47. A.S. De Groot, B. Jesdale, E. Szu, J.R. Schafer, R.M. Chics, and G. Deocampo An interactive Web site providing major histocompatibility ligand predictions: application to HIV research AIDS Res Hum Retroviruses 13 1997 529 531
48. J. Hammer, E. Bono, F. Gallazzi, C. Belunis, Z. Nagy, and F. Sinigaglia Precise prediction of major histocompatibility complex class-II peptide interaction based on peptide side chain scanning J Exp Med 180 1994 2353 2358
49. T. Sturniolo, E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, and M. Sahin Generation of tissue-specific and promiscuous HLA ligand data base using DNA microarrays and virtual HLA class II matrices Nat Biotech 17 1999 555 561
50. H. Singh, and G.P.S. Raghava ProPred: prediction of HLA-DR binding sites Bioinformatics 17 2001 1236 1237
51. M. Hagmann Computers aid vaccine design Science 290 2000 80 82
52. S. Manici, T. Sturniolo, M.A. Imro, J. Hammer, F. Sinigaglia, and C. Noppen Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leucocyte antigen DR11 J Exp Med 189 1999 871 876
53. J. Hammer, T. Sturniolo, and F. Sinigaglia HLA class II peptide binding specificity and autoimmunity Adv Immunol 66 1997 67 100
54. M. Panigada, T. Sturniolo, G. Besozzi, M.G. Boccieri, F. Sinigaglia, and G.G. Grassi Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins Infect Immun 70 2002 79 85
55. M. Vordermeier, A.O. Whelan, and R.G. Hewinson Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes Infect Immun 71 2003 1980 1987
56. A.S. De Groot, A. Bosma, N. Chinai, J. Frost, B.M. Jesdale, and M.A. Gonzalez From genome to vaccine: in silico predictions, ex vivo verification Vaccine 19 2001 4385 4395